Current and historical daily PE Ratio for IQVIA Holdings Inc (
STU:QTS
) from 2014 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. IQVIA stock (STU:QTS) PE ratio as of May 20 2024 is 31.58.
More Details
IQVIA Holdings Inc (STU:QTS) PE Ratio (TTM) Chart
IQVIA Holdings Inc (STU:QTS) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1267
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| IQVIA PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-20 | 31.4 | 2024-03-13 | 34.5 |
| 2024-05-17 | 31.4 | 2024-03-12 | 35.1 |
| 2024-05-16 | 32.1 | 2024-03-11 | 34.6 |
| 2024-05-15 | 31.7 | 2024-03-08 | 35.0 |
| 2024-05-14 | 31.5 | 2024-03-07 | 35.0 |
| 2024-05-13 | 31.4 | 2024-03-06 | 34.5 |
| 2024-05-10 | 31.4 | 2024-03-05 | 33.8 |
| 2024-05-09 | 31.1 | 2024-03-04 | 34.4 |
| 2024-05-08 | 31.3 | 2024-03-01 | 33.7 |
| 2024-05-07 | 31.0 | 2024-02-29 | 34.0 |
| 2024-05-06 | 31.0 | 2024-02-28 | 33.6 |
| 2024-05-03 | 30.7 | 2024-02-27 | 33.6 |
| 2024-05-02 | 30.8 | 2024-02-26 | 33.5 |
| 2024-04-30 | 32.1 | 2024-02-23 | 33.6 |
| 2024-04-29 | 32.3 | 2024-02-22 | 34.0 |
| 2024-04-26 | 32.6 | 2024-02-21 | 32.4 |
| 2024-04-25 | 32.1 | 2024-02-20 | 32.4 |
| 2024-04-24 | 33.1 | 2024-02-19 | 32.6 |
| 2024-04-23 | 33.1 | 2024-02-16 | 32.7 |
| 2024-04-22 | 31.9 | 2024-02-15 | 33.0 |
| 2024-04-19 | 31.6 | 2024-02-14 | 29.6 |
| 2024-04-18 | 31.5 | 2024-02-13 | 29.8 |
| 2024-04-17 | 31.6 | 2024-02-12 | 30.1 |
| 2024-04-16 | 31.9 | 2024-02-09 | 29.9 |
| 2024-04-15 | 32.2 | 2024-02-08 | 29.7 |
| 2024-04-12 | 32.4 | 2024-02-07 | 29.5 |
| 2024-04-11 | 32.7 | 2024-02-06 | 29.4 |
| 2024-04-10 | 32.9 | 2024-02-05 | 29.2 |
| 2024-04-09 | 33.4 | 2024-02-02 | 28.8 |
| 2024-04-08 | 33.0 | 2024-02-01 | 28.3 |
| 2024-04-05 | 32.4 | 2024-01-31 | 29.5 |
| 2024-04-04 | 33.0 | 2024-01-30 | 29.6 |
| 2024-04-03 | 33.4 | 2024-01-29 | 29.3 |
| 2024-04-02 | 34.0 | 2024-01-26 | 29.5 |
| 2024-03-28 | 34.4 | 2024-01-25 | 29.1 |
| 2024-03-27 | 34.1 | 2024-01-24 | 29.1 |
| 2024-03-26 | 33.8 | 2024-01-23 | 29.1 |
| 2024-03-25 | 34.0 | 2024-01-22 | 29.6 |
| 2024-03-22 | 34.7 | 2024-01-19 | 28.8 |
| 2024-03-21 | 34.3 | 2024-01-18 | 29.0 |
| 2024-03-20 | 34.3 | 2024-01-17 | 28.5 |
| 2024-03-19 | 34.5 | 2024-01-16 | 28.9 |
| 2024-03-18 | 34.4 | 2024-01-12 | 28.6 |
| 2024-03-15 | 34.5 | 2024-01-11 | 29.1 |
| 2024-03-14 | 34.5 | 2024-01-10 | 29.3 |
IQVIA Holdings Inc (STU:QTS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
IQVIA Holdings Inc
NAICS : 621399
SIC : 8099
ISIN : US46266C1053
Compare
Compare
Traded in other countries / regions
IQV.USA0JDM.UKQTS.GermanyIQV.MexicoI1QV34.BrazilIQVH.Austria IPO Date
2014-01-22Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers